Injective Revenue to FDV Ratio Tops Major Blockchains: Can INJ Benefit?

Injective's revenue to fully diluted valuation (FDV) ratio now leads major blockchain platforms in a 2026 year-to-date comparison, putting INJ ahead of better-known rivals on this metric. The strong ratio can support a valuation argument, but the catch remains whether it translates into sustained investor confidence and price appreciation for the token.